Answers are grounded in this paper and cite their sources.
e17588 Background: Exosome-derived miRNAs are detectable in various body fluids and play a crucial role in the diagnosis and prognosis of endometrial cancer (EC). The objective of our study is to investigate the clinical significance of an exosome-derived miRNA-based risk model, specifically focusing on miR-486-5p for EC. Methods: The expression profile of plasma-derived exosomal miRNAs was obtained through high-throughput sequencing. The expression profile of mature miRNAs for patients with EC was also obtained from TCGA. The prognostic value of differentially expressed miRNAs was assessed using R packages. The accuracy and stability of exosomal miRNAs in diagnosing EC were assessed using machine learning algorithms. The risk model based on exosome-derived miRNA was established using LASSO Cox regression analysis. The clinical significance of the risk model, including prognosis and anti-tumor therapy, was identified and validated using R packages. The most significant exosomal miRNA, miR-486-5p, was selected for wet experiments, including quantitative real-time PCR, Western Blot, CCK8, colony formation, transwell migration, wound healing, flow cytometry, and dual-luciferase reporter assays. Six databases and comprehensive bioinformatics approaches were integrated to predict targets of miR-486-5p. Data of single cell RNA was used to screen out the recipient cell of exosomal miR-486-5p. Results: A total of 49 exosomal miRNAs exhibited differential expression between plasma samples obtained from women with EC and controls. A total of 33 exosomal miRNAs exhibiting prognostic significance were identified. The area under the receiver operating characteristic curve (AUC) of the diagnostic model calculated by machine learning algorithms exceeded 0.9 in all sets. The risk model based on exosome-derived miRNA could be used to stratify EC patients with different prognosis. The AUC value of the time-dependent ROC curve for the risk model exceeded 0.7. Additionally, our study revealed that patients with EC, stratified based on the risk model, exhibited varying responses to anti-tumor therapy such as Tamoxifen. The single-cell transcriptome sequencing data revealed a significantly elevated expression abundance of FOXO1, the miR-486-5p target gene, in macrophages within the immune microenvironment. The experimental results demonstrated that miR-486-5p exerted a promotive effect on cellular proliferation, migration, invasion, and metabolic dysfunction through the inhibition of FOXO1. Furthermore, we observed that the exclusion of miR-148a-3p via exosomes promoted macrophage M2 polarization by FOXO1-mediated metabolic dysfunction. Conclusions: Our data has provided insights into the clinical significance of the risk model based on exosome-derived miRNA, as well as revealing the mechanism involving miR-486-5p in metabolic dysfunction through FOXO1 for endometrial cancer.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: